Oncopeptides Financial Statements From 2010 to 2025
| ONPPFDelisted Stock | USD 0.27 0.00 0.00% |
Check Oncopeptides financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncopeptides' main balance sheet or income statement drivers, such as , as well as many indicators such as . Oncopeptides financial statements analysis is a perfect complement when working with Oncopeptides Valuation or Volatility modules.
Oncopeptides |
Oncopeptides AB Company Return On Equity Analysis
Oncopeptides' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Oncopeptides Return On Equity | -1.29 |
Most of Oncopeptides' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oncopeptides AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Oncopeptides AB has a Return On Equity of -1.2916. This is 94.61% lower than that of the Healthcare sector and 96.46% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Oncopeptides AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oncopeptides's current stock value. Our valuation model uses many indicators to compare Oncopeptides value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oncopeptides competition to find correlations between indicators driving Oncopeptides's intrinsic value. More Info.Oncopeptides AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oncopeptides' earnings, one of the primary drivers of an investment's value.About Oncopeptides Financial Statements
Oncopeptides stakeholders use historical fundamental indicators, such as Oncopeptides' revenue or net income, to determine how well the company is positioned to perform in the future. Although Oncopeptides investors may analyze each financial statement separately, they are all interrelated. For example, changes in Oncopeptides' assets and liabilities are reflected in the revenues and expenses on Oncopeptides' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Oncopeptides AB. Please read more on our technical analysis and fundamental analysis pages.
Oncopeptides AB , a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Oncopeptides AB was incorporated in 2000 and is headquartered in Stockholm, Sweden. Oncopeptides is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Oncopeptides Pink Sheet
If you are still planning to invest in Oncopeptides AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncopeptides' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |